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Dysfunctional cell signaling is a common attribute in many disorders, and there is great interest in 
understanding the complex pathways that govern interactions and responses within our cells. These 
mechanisms can be studied through quantification of protein levels as well as covalent modification 
to proteins, so called post-translational modifications (PTM). A PTM with both biological and clinical 
relevance is phosphorylation - the addition of a phosphate group, which alters the function and 
activity of the target protein. Studies of phosphorylation signaling could help identify potential new 
drug targets, but a lack of adequate tools has stood in the way of progress - a situation that may be 
about to change. In a recent publication in Molecular & Cellular Proteomics, Drs. Jeffrey Whiteaker 
and Amanda Paulovich from Fred Hutch's Clinical Research Division describe a new multiplex assay 
that could provide the answer to many a researcher's litanies. 
Countless scientific advances have been made courtesy of traditional analytical techniques like 
western blotting and the enzyme-linked immunosorbent assay (ELISA), but these one-analyte-at-a-
time assays fail to live up to the demands placed by advanced modern-day "omics" technologies 
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(e.g. genomics, proteomics). Higher throughput, improved specificity, and better reproducibility are 
needed - preferably at a lower cost. Advances in the field of mass spectrometry (MS) has led to 
expansion of targeted MS, enabling precise quantification of protein-specific peptide sequences, the 
most commonly utilized form being multiple reaction monitoring (MRM). MRM-based assays provide 
direct measurement of the analyte and are recognized for yielding reliable output that can be 
reproduced independent of laboratory, thanks to the use of stable, synthetic internal standards. 
Compared with other techniques, these assays are highly specific, easily multiplexable, and 
comparatively quick and cheap. 
The Fred Hutch investigators set out to combine MRM with antibody-based affinity-enrichment using 
immobilized antibodies on magnetic beads, an immuno-enrichment method previously optimized by 
the Paulovich Lab (Whiteaker et al. 2007). To demonstrate proof-of-concept, an immuno-MRM 
assay was tested for quantification of phospho-signaling in an important network, the DNA damage 
response (DDR) network, which has been shown to commonly display mutations in tumors. 
Successful monitoring of variations in DDR activity could have major effects on basic, clinical, and 
public health studies. The resulting multiplex assay proved applicable for a wide range of samples 
and conditions, efficiently replacing no less than 69 western blots with one single 40-minute run. 
Dr. Whiteaker explained that the results were superior compared with those of semi-quantitative, 
often poorly specific, traditional methods, and that this moderate- to high-throughput MRM assay 
proved to be just what they hoped for: quantitative, precise, and specific. "Reliable methods for 
quantifying proteins and post-translational modifications are necessary tools for understanding the 
molecular basis of cellular signaling in diseased cells and profiling pharmacodynamic responses of 
new and existing therapeutics," he continued, underlining the broad impact of the innovation. 
From here, there are multiple possibilities to further advance the technique. "We are very excited to 
continue developing these assays, expanding assay content, and getting this technology into the 
hands of more biologists," Dr. Whiteaker concluded. There should be quite a few researchers out 
there that share his gusto. 
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